Clinical Trial

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Name: Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis — clinical trial record (NCT07023835)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: UNITE-ALS

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Protocol Amendment History 1 change

critical Enrollment reopened 2026-07-29

Trial Details

NCT Number	NCT07023835
Lead Sponsor	Zydus Therapeutics Inc.
Conditions	Amyotrophic Lateral Sclerosis (ALS)
Enrollment	240 participants
Start Date	2025-09-17
Primary Completion	2028-03 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-28